Pharma Nord Eesti OÜRegistered
Key figures
780 813 €−6,9%
Revenue 2025
+20,0%
Average annual growth 2019–2025
Ratios
20254,2%
Profit margin
6,7%
EBITDA margin
37,8%
Equity ratio
1,6×
Current ratio
67,7%
Return on equity
3384 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 303 429 € | 6 | 33 486 € |
| Q1 2026 | 244 609 € | 7 | 32 799 € |
| Q4 2025 | 269 155 € | 7 | 33 204 € |
| Q3 2025 | 201 357 € | 7 | 33 548 € |
| Q2 2025 | 287 422 € | 7 | 36 665 € |
| Q1 2025 | 206 118 € | 7 | 34 508 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
Distributed as dividends 33 647 € (72% of distributable profit).
History
202533 647 €
202457 280 €
20230 €
202218 400 €
202136 623 €
20200 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 72 933 | 81 861 | 81 173 | 146 356 | 359 805 | 291 923 | 125 302 |
| Total non-current assets | 1141 | 8043 | 6565 | 6117 | 4745 | 5956 | 3287 |
| Total assets | 74 074 | 89 904 | 87 738 | 152 473 | 364 550 | 297 879 | 128 589 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 17 189 | 18 091 | 45 515 | 125 605 | 288 151 | 248 514 | 79 936 |
| Non-current liabilities | 16 035 | 16 035 | 16 035 | 0 | — | — | — |
| Total liabilities | 33 224 | 34 126 | 61 550 | 125 605 | 288 151 | 248 514 | 79 936 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | 25 245 | 38 350 | 16 655 | 5288 | 24 368 | 16 619 | 13 218 |
| Profit for the year | 13 105 | 14 928 | 7033 | 19 080 | 49 531 | 30 246 | 32 935 |
| Total equity | 40 850 | 55 778 | 26 188 | 26 868 | 76 399 | 49 365 | 48 653 |
| Income statement | |||||||
| Sales revenue | 262 097 | 298 566 | 333 787 | 509 173 | 700 869 | 838 976 | 780 813 |
| Operating profit | 13 616 | 15 455 | 16 731 | 22 897 | 49 531 | 44 052 | 49 286 |
| EBITDA | 13 872 | 16 324 | 18 912 | 25 131 | 51 839 | 46 715 | 51 955 |
| Profit before income tax | 13 105 | 14 928 | 16 189 | 22 615 | 49 531 | 42 966 | 42 425 |
| Profit for the reporting year | 13 105 | 14 928 | 7033 | 19 080 | 49 531 | 30 246 | 32 935 |
| Labour costs | 120 688 | 137 898 | 164 525 | 191 596 | 246 436 | 305 123 | 296 203 |
| Depreciation of non-current assets | 256 | 869 | 2181 | 2234 | 2308 | 2663 | 2669 |
| Other indicators | |||||||
| Employees | 5 | 5 | 5 | 5 | 7 | 9 | 7 |
| Calculated dividend | — | 0 | 36 623 | 18 400 | 0 | 57 280 | 33 647 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Other information service activities